Clinical Trials Logo

Vitreous Floaters clinical trials

View clinical trials related to Vitreous Floaters.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06174935 Not yet recruiting - Vitreous Floaters Clinical Trials

Low Dose Atropine for Symptomatic Vitreous Floaters

Start date: January 1, 2024
Phase: Phase 2
Study type: Interventional

The objective of this study is to identify a potential pharmacologic option by assessing whether 0.01% atropine may be effective for treating bothersome floaters as measured by scores on a modified NEI VFQ-25.